Bio-Rad Laboratories, Inc. Class A Common Stock vs Sunrun Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Sunrun Inc trades at $12.86 (market cap $2.96B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 2.7× Sunrun Inc's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| BIO | RUN | |
|---|---|---|
Market Cap | $8.02B | $2.96B |
Sector | Health | Technology |
52-Week High | $339.75 | $21.41 |
52-Week Low | $241.71 | $9.07 |
Enterprise Value | $7.84B | $17.16B |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →